Therapeutic strategies were designed based on experience from the treatment
options of the last 10 years in the ordinary clinical setting.
Interferon was the first treatment used. This monotherapy was discontinued
with the arrival of ribavirin, Ribavirin monotherapy has also been shown to
have a limited effect and in recent years the combination of interferon an
d ribavirin has become the first line therapy.